Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trialElizabeth A. Mittendorf, Nadia Harbeck, Kyung Hae Jung et al.|The Lancet|2020Cited by 1.1k
Breast cancer patient delay in Fukushima, Japan following the 2011 triple disaster: a long-term retrospective studyAkihiko Ozaki, Hiromichi Ohira, Shuhei Nomura et al.|BMC Cancer|2017Cited by 64
E3 Ubiquitin Ligase NEDD4 Affects Estrogen Receptor α Expression and the Prognosis of Patients with Hormone Receptor-Positive Breast CancerYutaka Natori, Shigehira Saji|Cancers|2023Cited by 8